UB Paderborn / Katalog / Suche / in CDI

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

Gut, 2009-03, Vol.58 (3), p.357-365

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of prucalopride on symptoms of chronic constipation

Neurogastroenterology and motility, 2014-01, Vol.26 (1), p.21-27

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety assessment of prucalopride in elderly patients with constipation: a double‐blind, placebo‐controlled study

Neurogastroenterology and motility, 2009-12, Vol.21 (12), p.1256-e117

2009

Link zum Volltext

Verfügbarkeit prüfen

Association between health‐related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride

Neurogastroenterology and motility, 2015-03, Vol.27 (3), p.397-405

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.48-55

2012

Link zum Volltext

Verfügbarkeit prüfen

A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation

Neurogastroenterology and motility, 2010-09, Vol.22 (9), p.991-e255

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial: the efficacy of open‐label prucalopride treatment in patients with chronic constipation – follow‐up of patients from the pivotal studies

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1113-1123

2010

Link zum Volltext

Verfügbarkeit prüfen

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

The New England journal of medicine, 2008-05, Vol.358 (22), p.2344-2354

2008

Link zum Volltext

Verfügbarkeit prüfen

Response of chronic constipation symptoms to prucalopride treatment and relationship with patient satisfaction

Gut, 2011-04, Vol.60 (Suppl 1), p.A159-A159

2011

Link zum Volltext

Verfügbarkeit prüfen

Best response distribution of 12-week treatment with prucalopride (RESOLOR) in patients with chronic constipation: combined results of three randomised, double-blind, placebo-controlled phase iii trials

Gut, 2011-04, Vol.60 (Suppl 1), p.A159-A160

2011

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of oral treatment with pramiconazole in pityriasis versicolor: a phase II a trial

British journal of dermatology (1951), 2007-06, Vol.156 (6), p.1385-1387

2007

Link zum Volltext

Verfügbarkeit prüfen

Activity of the Triazole Antifungal R126638 as Assessed by Corneofungimetry

Skin pharmacology and physiology, 2006-01, Vol.19 (1), p.50-56

2006

Link zum Volltext

Verfügbarkeit prüfen

Gastroenterology

Age and ageing, 2013-08, Vol.42 (suppl 3), p.iii18-iii18

2013

Link zum Volltext

Verfügbarkeit prüfen

PTH-047 Safety and tolerability of prucalopride (resolor) in patients with chronic constipation: pooled data from three pivotal phase 3 studies: Abstract PTH-047

Gut, 2010-04, Vol.59 (Suppl 1), p.A141-A142

2010

Link zum Volltext

Verfügbarkeit prüfen

PTH-047 Safety and tolerability of prucalopride (resolor) in patients with chronic constipation: pooled data from three pivotal phase 3 studies

Gut, 2010-04, Vol.59 (Suppl 1), p.A141

2010

Link zum Volltext

Verfügbarkeit prüfen

OC-069 Efficacy of 12-week treatment with prucalopride (resolor) in patients with chronic constipation: combined results of three randomised, double-blind, placebo-controlled phase 3 trials

Gut, 2010-04, Vol.59 (Suppl 1), p.A28-A29

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

Drug design, development and therapy, 2012-01, Vol.6 (default), p.407-415

2012

Link zum Volltext

Verfügbarkeit prüfen

PG15 PREDICTORS FOR RESPONSE TO PRUCALOPRIDE IN PATIENTS WITH CHRONIC CONSTIPATION

Value in health, 2009, Vol.12 (7), p.A346-A346

2009

Link zum Volltext

Verfügbarkeit prüfen

Effects of R 56865 and Phenytoin on Mechanical, Biochemical, and Morphologic Changes During Ouabain Intoxication in Isolated Perfused Rabbit Heart

Journal of cardiovascular pharmacology, 1992-09, Vol.20 (3), p.421-428

1992

Link zum Volltext

Verfügbarkeit prüfen

Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

The European respiratory journal, 2022-05, Vol.59 (5)

2022

Link zum Volltext

Verfügbarkeit prüfen

R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

The European respiratory journal, 2022-05, Vol.59 (5), p.2101293

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral Prucalopride in Children With Functional Constipation

Journal of pediatric gastroenterology and nutrition, 2013-08, Vol.57 (2), p.197-203

2013

Link zum Volltext

Verfügbarkeit prüfen

A new method to study activated oxygen species induced damage in cardiomyocytes and protection by Ca 2+-Antagonists

Journal of molecular and cellular cardiology, 1988-09, Vol.20 (9), p.811-823

1988

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of Cardiomyocytes

Annals of the New York Academy of Sciences, 1988, Vol.522 (1), p.433-453

1988

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of factors influencing myocardial infarct size in unconscious dogs

Cardiovascular research, 1991-10, Vol.25 (10), p.844-854

1991

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

Effect of prucalopride on symptoms of chronic constipation

Safety assessment of prucalopride in elderly patients with constipation: a double‐blind, placebo‐controlled study

Association between health‐related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study

A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation

Clinical trial: the efficacy of open‐label prucalopride treatment in patients with chronic constipation – follow‐up of patients from the pivotal studies

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

Response of chronic constipation symptoms to prucalopride treatment and relationship with patient satisfaction

Best response distribution of 12-week treatment with prucalopride (RESOLOR) in patients with chronic constipation: combined results of three randomised, double-blind, placebo-controlled phase iii trials

The efficacy of oral treatment with pramiconazole in pityriasis versicolor: a phase II a trial

Activity of the Triazole Antifungal R126638 as Assessed by Corneofungimetry

Gastroenterology

PTH-047 Safety and tolerability of prucalopride (resolor) in patients with chronic constipation: pooled data from three pivotal phase 3 studies: Abstract PTH-047

PTH-047 Safety and tolerability of prucalopride (resolor) in patients with chronic constipation: pooled data from three pivotal phase 3 studies

OC-069 Efficacy of 12-week treatment with prucalopride (resolor) in patients with chronic constipation: combined results of three randomised, double-blind, placebo-controlled phase 3 trials

Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

PG15 PREDICTORS FOR RESPONSE TO PRUCALOPRIDE IN PATIENTS WITH CHRONIC CONSTIPATION

Effects of R 56865 and Phenytoin on Mechanical, Biochemical, and Morphologic Changes During Ouabain Intoxication in Isolated Perfused Rabbit Heart

Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease

Oral Prucalopride in Children With Functional Constipation

A new method to study activated oxygen species induced damage in cardiomyocytes and protection by Ca 2+-Antagonists

Pathophysiology of Cardiomyocytes

Evaluation of factors influencing myocardial infarct size in unconscious dogs

Suchergebnisse filtern